Simple Screener Can Identify Need for Resource Support in Families With SCD
Researchers sought to determine whether the Psychosocial Assessment Tool would be able to identify families of patients with SCD in need of resource support.
All articles by Andrea S. Blevins Primeau, PhD, MBA
Childhood Cancer Survivors Have Higher Risk of Late Surgical Interventions
Childhood cancer survivors have a higher risk of requiring surgical interventions up to 35 years after diagnosis, a large study suggests.
Few Cancer Drugs Are Approved Within 10 Years of Entering Trials
The probability that a cancer drug would receive FDA approval within 10 years of entering trials was 10.4%, researchers found.
CAR T-Cells May Be Safe in Non-Transplant Eligible Patients With Large B-Cell Lymphoma
Researchers sought to determine whether CAR-T therapy would be a viable option for patients with relapsed/refractory large B-cell lymphoma.
High CMR Rates Seen With Nivolumab Plus Brentuximab Vedotin in CAYA Relapsed/Refractory Hodgkin Lymphoma
Researchers sought to determine whether combining nivolumab plus brentuximab vedotin would improve response rates in CAYAs with Hodgkin lymphoma.
MIS-C Increases Risk of Hospitalization, Death in Cancer Patients With COVID-19
Pediatric cancer patients who develop MIS-C after COVID-19 have a worse clinical course than patients without MIS-C, a study suggests.
Clinicogenomic Analysis Confirms Poor Outcomes in T-ALL After Induction Failure
Researchers sought to determine whether a clinicogenomic analysis of T-ALL would be able to confirm poor outcomes despite treatment with chemotherapy and HSCT.
Ferric Carboxymaltose Failed to Improve Anemia in Pregnant Women
Researchers sought to determine whether ferric carboxymaltose would improve anemia in pregnant women living in sub-Saharan Africa.
Allogeneic HSCT Prolonged PFS in Advanced-Stage CTCL
Researchers sought to determine whether allogeneic HSCT would improve survival in patients with advanced-stage CTCL.
Clinical Indicators Associated With Arsenic-Induced Hepatotoxicity in APL
Researchers sought to determine clinical indicators that are associated with ATO-induced hepatotoxicity in patients with APL.
- Loading...
Loading...
Next post in Leukemia
Loading... 
Loading...